(P-406) Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎

Location: Poster Gallery-Drug Utilization Research

Presenting Author(s)

AA

Ali Ojaym Alsulaiman

King Khalid Hospital in Najran
Najran, Najran, Saudi Arabia

Co-Author(s)

AA

Ahmed A. Alswar

King Khalid Hospital in Najran, Saudi Arabia, Saudi Arabia
HA

Hadi A. Almansour

School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia, Australia
MS

Mohamed S. Sheik

Riyadh Elm University, Riyadh, Saudi Arabia, Saudi Arabia
AA

Abdulaziz Alhossan

Department of Clinical Pharmacy, King Saud University, Saudi Arabia, Saudi Arabia

Background:

Background: Although the role of pharmacist-led anticoagulation clinics (ACCs) has been accepted ‎and implemented in other countries, the evidence demonstrating the effects comparing a clinical ‎pharmacist-managed ACC with usual physician care in the Kingdom of Saudi Arabia (KSA) is lacking.

Objectives: ‎

Objectives: The objective of this study was to compare the effectiveness of clinical pharmacist-‎managed ACC with usual physician care using International Normalized Ratio (INR) stability. ‎

Methods:

Methods: A retrospective cross-sectional study was conducted from December 2018 to June 2020 ‎at Family Medicine Clinic of King Khalid Hospital. All consecutive patients who attended the ACC ‎between December 2018 to June 2020 and referred with 4 months of prior anticoagulation ‎management who also had anticoagulation management for 4 months within the ACC were ‎included in the evaluation. Descriptive and inferential statistics were used to report the data. ‎

Results:

Results: Warfarin was commonly prescribed for atrial fibrillation, deep venous thrombosis, ‎pulmonary embolism, and mechanical valve replacement. There was a need of dose adjustments ‎for warfarin in more than two-thirds of the patients. The findings showed that patients in a ‎pharmacist group had relatively a higher percentage (97.1%) of good INR control xii than patients ‎in physician group (85.2%). There was a statistically significant difference between pharmacist and ‎physician group in both the therapeutic ranges of INR. ‎

Conclusions:

Conclusion: This study was conducted to establish that a pharmacist-led ACC was just as effective ‎at managing patients on anticoagulation therapy. As the results demonstrated, pharmacists can ‎stabilize and maintain stabilization in INR values. This may be due to pharmacist’s expertise in ‎pharmacotherapy that may affect the INR. The findings also inform the trust of patients on the ‎skills of pharmacists in ACC. However, further studies with larger sample size from all the regions ‎of the KSA are required to validate the findings of this study.‎